New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type-2 diabetes drugs at a 30 per cent lower price, in alleged violation of Merck's intellectual property rights.
Merck had introduced its drugs in India in 2008, pegged at one-fifth the United States price. According to market sources, a strip of seven tablets of Januvia (50 mg and 100 mg) is priced at Rs 300 while Glenmark's version costs around 30 per cent less.
MSD, in its plea, had alleged that the Indian pharma company has violated its intellectual property right (IPR) over its anti-diabetes medicines, Januvia and Janumet, by coming in the market with their own drugs containing the same salts.
(With Additional Information From PTI)...
more
10:15 AM, May 23, 2013
New Delhi: Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in India. It is the largest settlement by a generic medicine maker till date. It includes $150 million in payments for a criminal fine and forfeiture and $350 million in payments for civil claims. The adulterated drugs were made in Ranbaxy's plants in India and...
08:30 AM, May 14, 2013
New York: The US government has sued Novartis Pharmaceuticals Corp, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own. The civil health care fraud lawsuit in US District Court in Manhattan seeks unspecified damages and civil penalties for a scheme that the government said has been carried out since 2005. US Attorney Preet Bharara said on Tuesday that the company used the...
09:00 AM, Apr 24, 2013
New Delhi: The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim application of the multinational pharma major the Mumbai-based firm be restrained from manufacturing and selling the anti-diabetes medicines on the...
05:54 PM, Apr 05, 2013
The CBI, probing the alleged disproportionate assets case involving YSR Congress chief YS Jaganmohan Reddy, on Monday said it could file a supplementary chargesheet in the case on Tuesday. The central agency made this submission before a special CBI court here while seeking extension of judicial remand of Jagan and other accused. ...
10:45 AM, Apr 02, 2013
In a landmark verdict, the Supreme Court dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving the way for more affordable life-saving cancer drugs. How does it affect the Indian pharmaceutical industry and the global biggies who are looking at India as a quick-growth market? Pharmaceutical industry expert Vikas Dandekar joined IBNLive readers for an interaction on the issue....
05:30 PM, Apr 01, 2013
Pharmaceutical giant Novartis on Monday termed the Supreme Court's judgement of not granting a patent to its cancer drug Glivec as "disappointing" and warned that though it will continue to introduce new products in India, it will now invest "cautiously". In a landmark verdict, the apex court dismissed the Swiss company's plea, paving way for more affordable life saving cancer drugs. ...
03:28 PM, Apr 01, 2013
Swiss pharmaceutical company Novartis, which lost its battle for patent on its cancer drug Glivec in India on Monday, said the Supreme Court's ruling discourages innovative drug discovery and is a setback for patients. ...
01:38 PM, Apr 01, 2013
Shares of the Swiss pharmaceutical giant Novartis fell about 4.5 per cent on Monday after the Supreme Court of India dismissed its plea for a patent on its cancer drug, Gelvic. Shares of select Indian pharmaceutical companies rallied as the industry is set to receive a boost following the verdict. ...
11:48 AM, Apr 01, 2013
The Supreme Court on Monday is likely to pronounce its verdict in the much awaited patent case involving Glivec - the anti-cancer drug manufactured by Swiss pharma-giant Novartis - priced at a whopping Rs 1.2 lakhs for a monthly dosage. The case dates back to India's denial of a patent in 2006 on the grounds that it wasn't considered a new molecule, but an altered version of one that had...
08:37 AM, Apr 01, 2013
The Supreme Court will pronounce an important judgment on Monday on a Swiss pharma firm's plea asserting its patent over a medicine, and Tuesday take up Sterlite's plea opposing the order to shut down its plant as well as the case of the Italian marines. ...
04:20 AM, Apr 01, 2013
The government on Friday said it has approved 12 FDI proposals, including that of pharma firm Claris Otsuka, totalling over Rs 2,609 crore. The Foreign Investment Promotion Board (FIPB) headed by Economic Affairs Secretary Arvind Mayaram, also cleared the proposal of Decathlon Sports India's proposal for induction of foreign equity worth Rs 700 crore to engage in single brand retail. ...
03:35 PM, Mar 22, 2013
Dhoni, has been signed as the brand ambassador of Emcure Pharmaceuticals, a company that specialises in tablets, capsules, injectables and Onco products. ...
11:48 PM, Mar 12, 2013
The US arm of Indian drug major Ranbaxy Laboratories has entered into an in-licensing agreement with Alembic Pharmaceuticals Limited to exclusively market the generic version of Pfizer Inc.'s anti-depression drug Pristiq in the US. ...
01:55 PM, Mar 06, 2013
A 27-year-old pharmacology student was found dead in her hostel room in the All India Institute of Medical Sciences (AIIMS) on Tuesday, police said. They suspect it to be a case of suicide. ...
04:14 PM, Mar 05, 2013
Shares in Natco Pharma Ltd surge 5.3 per cent after an Indian patent appeals board upheld on Monday a decision to allow the company to sell a generic version of Bayer AG's cancer drug Nexavar. ...
12:35 PM, Mar 05, 2013
Healthcare and pharmaceutical industries on Thursday welcomed steps announced in the Budget to increase allotment on health and medical education. However, private players expressed concern that Finance Minister P Chidambaram could have provided support in the form of tax incentives as well. ...
06:08 PM, Feb 28, 2013
Prisoners in Ananthapur in Andhra Pradesh are getting a second chance in life. Through a unique rehabilitation program started by the pharmaceutical company Himalaya, the inmates are now turning to herb farming. ...
10:20 AM, Feb 19, 2013
Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to shift operations elsewhere, adding to their costs. ...
02:20 AM, Feb 13, 2013
Saudi Labor Minister Adel Faqih announced on the weekend that women will soon be allowed to work in pharmacies, a job held only by men so far, media reports said. Faqih said at a private business event that his ministry was working to prepare a "safe and proper" environment that guarantees the employment of women in pharmacies. ...
12:50 PM, Feb 04, 2013
